Analysis highlights the unequal economic distribution of data in medicine, suggesting pathways for innovation and fairness.
Data are the engine of modern medicine, yet its economic trade-off remains unequally distributed: hospitals and research institutions shoulder the effort of collection, while life science companies reap the financial rewards. This imbalance raises pressing questions about fairness, rights and sustainability.
No takes yet. Share an insight, caveat, or question.
Michael Byczkowski (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: